ArticleTherapeutic advances in medical oncology2024

Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchioloalveolar carcinoma).

Young Kwang Chae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.